Acthrel    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
75Cushing disease2

75. Cushing disease    [ 191 clinical trials,   172 drugs,   (DrugBank: 48 drugs),   61 drug target genes,   121 drug target pathways]
Searched query = "Cushing disease", "Cushing"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 191 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04569591
(ClinicalTrials.gov)
December 17, 202029/9/2020Corticotrophin-releasing Hormone (CRH) Stimulation for 18F-FDG-PET Detection of Pituitary Adenoma in Cushing s DiseaseCorticotrophin-Releasing Hormone (CRH) Stimulation for 18F-FDG-PET Detection of Pituitary Adenoma in Cushing's DiseaseCushing's Disease;Pituitary AdenomaDrug: ActhrelNational Institute of Neurological Disorders and Stroke (NINDS)NULLRecruiting8 YearsN/AAll22N/AUnited States
2NCT01459237
(ClinicalTrials.gov)
October 11, 201121/10/2011Effects of Hormone Stimulation on Brain Scans for Cushing s DiseaseProspective Evaluation of the Effect of Corticotropin-Releasing Hormone Stimulation on 18F-Fludeoxyglucose High-Resolution Positron-Emission Tomography in Cushing's DiseasePituitary NeoplasmDrug: ActhrelNational Institute of Neurological Disorders and Stroke (NINDS)NULLCompleted8 YearsN/AAll30Early Phase 1United States